Mesenchymal stem cell therapy improves erectile dysfunction in experimental spinal cord injury

Area of Science:

• Regenerative Medicine
• Neuroscience
• Urology

Background:

• Spinal cord injury (SCI) frequently leads to erectile dysfunction (ED).
• Current treatments for SCI-induced ED are limited.
• Mesenchymal stem cells (MSCs) show potential for tissue repair.

Purpose of the Study:

• To investigate the therapeutic effects of adipose-derived mesenchymal stem cells (AD-MSCs) from brown adipose tissue on experimentally induced erectile dysfunction in rats with spinal cord injury.
• To evaluate the impact of AD-MSC therapy on neurological function, erectile function, and specific molecular markers in SCI rats.

Main Methods:

• Male Wistar rats underwent moderate to severe spinal cord injury (T7-T10) using a weight-drop method.
• AD-MSCs (3 × 10^5 cells) were transplanted locally into the injury site in the treatment group.
• Neurological function, intracavernosal pressure (ICP)/mean arterial pressure (MAP) ratios, and levels of nerve growth factor (NGF), n-NOS, and c-FOS in spinal cord and cavernosal tissues were assessed after four weeks.

Main Results:

• SCI significantly altered NGF, n-NOS, and c-FOS levels, and impaired erectile function (increased ICP/MAP ratio).
• AD-MSC treatment reversed these changes, restoring erectile function and molecular markers towards control levels.
• Histological examination supported the amelioration of neuronal damage.

Conclusions:

• AD-MSC therapy demonstrates significant therapeutic potential for erectile dysfunction in the context of spinal cord injury.
• Treatment with AD-MSCs may ameliorate neuronal damage and restore physiological functions affected by SCI.
• Brown adipose tissue-derived MSCs represent a promising cell source for regenerative strategies targeting SCI-induced ED.